Modified FGF4 signal peptide inhibits entry of herpes simplex virus type 1.
about
Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cellsMultiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infectionCathelicidin LL-37 and HSV-1 Corneal Infection: Peptide Versus Gene Therapy.Peptide therapeutics for treating ocular surface infectionsHuman cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity.Virus aggregating peptide enhances the cell-mediated response to influenza virus vaccineUpdate on emerging antivirals for the management of herpes simplex virus infections: a patenting perspective.Antiviral activity of the EB peptide against zoonotic poxviruses.A cationic peptide, TAT-Cd°, inhibits herpes simplex virus type 1 ocular infection in vivo.Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells.AVPdb: a database of experimentally validated antiviral peptides targeting medically important viruses.Inhibition of herpes simplex virus type 1 infection by cationic beta-peptides.Cell-Penetrating Peptides for Antiviral Drug Development.Identification of the minimal active sequence of an anti-influenza virus peptide.A cationic TAT peptide inhibits Herpes simplex virus type 1 infection of human corneal epithelial cells.The virucidal EB peptide protects host cells from herpes simplex virus type 1 infection in the presence of serum albumin and aggregates proteins in a detergent-like manner.Induction of interleukin-6 in human retinal epithelial cells by an attenuated Herpes simplex virus vector requires viral replication and NFkappaB activation.Addition of a C-terminal cysteine improves the anti-herpes simplex virus activity of a peptide containing the human immunodeficiency virus type 1 TAT protein transduction domain.Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.Peptides containing membrane-transiting motifs inhibit virus entry.The Amphibian Antimicrobial Peptide Temporin B Inhibits In Vitro Herpes Simplex Virus 1 Infection.
P2860
Q27021069-16704E2F-1B98-4427-86C6-DC8BDAF67688Q30357092-B0774C28-110B-4F5D-ACF7-B23F3F0E94AEQ33395218-FAC608CE-12A6-437F-B82D-65EA82988B76Q33704754-78E1814C-7A9C-4673-9E6E-86F0ADDDCADFQ34454864-2B5784E8-1271-4118-91B1-EEA8849C106AQ34758057-E1802B29-3B2A-4FAA-BA96-8BA635C973F2Q35301495-D610F667-0A6F-4EB6-A6E5-755F5E165E55Q35531731-798FA594-0CD1-4F21-A73F-E41BCD4708DAQ35744848-E3F7B885-BD1F-4346-91A8-F9AC284C7066Q36591817-F7092943-F75D-40F2-9331-9A0180930E69Q37567824-E5F124B2-3467-4A35-878F-C809671AD1B4Q38490669-68EB7279-BF08-47C5-BB17-60822048761EQ38899213-D1E5ECBE-7B29-4361-955C-41D320948AAFQ38974187-F7F52050-D923-40C7-999A-D99AC54C74C1Q39609650-F0C9D76D-2765-43D8-95A8-4A208878E23CQ39638812-625DA4C6-A270-4DBF-9A77-75CAB527A93FQ39678336-218581A9-E3A4-43B8-8690-A8BAA91AC08DQ41813743-BEBA6119-8D4E-40A4-A697-F30B5EC0FA5CQ42138358-D1B734D0-B697-4A48-BCEB-664519474433Q42143723-E170635A-62D4-4B52-85DD-0D979B16CB47Q45731678-8E2BECC7-F360-4611-9124-DA325DDC7B42Q51747345-DAC977ED-E19A-44D3-851B-A4D15F96BBA6
P2860
Modified FGF4 signal peptide inhibits entry of herpes simplex virus type 1.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Modified FGF4 signal peptide inhibits entry of herpes simplex virus type 1.
@en
Modified FGF4 signal peptide inhibits entry of herpes simplex virus type 1.
@nl
type
label
Modified FGF4 signal peptide inhibits entry of herpes simplex virus type 1.
@en
Modified FGF4 signal peptide inhibits entry of herpes simplex virus type 1.
@nl
prefLabel
Modified FGF4 signal peptide inhibits entry of herpes simplex virus type 1.
@en
Modified FGF4 signal peptide inhibits entry of herpes simplex virus type 1.
@nl
P2093
P2860
P1433
P1476
Modified FGF4 signal peptide inhibits entry of herpes simplex virus type 1.
@en
P2093
P2860
P304
P356
10.1128/JVI.75.6.2634-2645.2001
P407
P577
2001-03-01T00:00:00Z